In an effort to produce further direct experimental evidence supporting the above hypothesis, in this report, we have evaluated the effect of specific SOS1 and/or SOS2 genetic ablation on a mouse model of p210BCR/ABL-driven CML. Here, SOS1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.